Quantech deal

QQQQ executed a letter of intent to purchase all the outstanding shares of HybriLogic Corp. in exchange for 600,000 shares of QQQQ. The company said HybriLogic will provide the antibody supply QQQQ needs to develop its surface plasmon resonance (SPR) system, a biosensor that detects mass structural changes of an antibody on a gold grating. Joseph Shaw, president and CEO of QQQQ, said the deal is capped at $1 million and should close within 30 to 60 days. ...